Literature DB >> 22844066

Does preoperative steroid treatment affect the histology in giant cell (cranial) arteritis?

Danielle Bury1, Jacob Joseph, Timothy P Dawson.   

Abstract

INTRODUCTION: Giant cell arteritis (GCA) has been successfully treated with steroids for many years and temporal artery biopsy (TAB) is regarded as the gold standard diagnostic test. The primary aim of this study was to determine whether steroid pretreatment abrogates histological features of GCA reducing diagnostic return, as suspected on the basis of anecdotal evidence. This impacts upon patients suspected of having GCA and the need for prompt treatment balanced with the diagnostic need for TAB.
METHODS: A 6-year single-centre retrospective study of biopsies (2005-2011) was performed with interrogation of the medical notes for information regarding steroid use. The null hypothesis considered there was no association between steroid use and biopsy outcome.
RESULTS: No significant difference was found between steroid use and biopsy outcome, with biopsies still producing positive results after weeks of steroid treatment.
CONCLUSIONS: TAB is still useful in the diagnosis of GCA, even after commencing steroid treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22844066     DOI: 10.1136/jclinpath-2012-200870

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

Review 1.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 2.  Visual loss and other cranial ischaemic complications in giant cell arteritis.

Authors:  Alessandra Soriano; Francesco Muratore; Nicolò Pipitone; Luigi Boiardi; Luca Cimino; Carlo Salvarani
Journal:  Nat Rev Rheumatol       Date:  2017-07-06       Impact factor: 20.543

3.  Combined bilateral ophthalmic artery occlusion & central retinal vein occlusion from presumed giant cell arteritis.

Authors:  Mark Hankins; Sarina Amin; Andres Gonzalez; Hazem Samy
Journal:  Am J Ophthalmol Case Rep       Date:  2018-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.